Fate Therapeutics (FATE) names Matthew Abernethy to Board
Go back to Fate Therapeutics (FATE) names Matthew Abernethy to Board| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.33 -0.11 (4.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.44 | 52 Week High | $4.76 | |||
| Open | $2.42 | 52 Week Low | $1.46 | |||
| Day High | $2.45 | P/E | N/A | |||
| Day Low | $2.28 | EPS | $-1.91 | |||
| Volume | 751,112 | |||||
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 156.57 +1.43 (0.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $155.14 | 52 Week High | $58.46 | |||
| Open | $154.38 | 52 Week Low | $31.25 | |||
| Day High | $159.94 | P/E | N/A | |||
| Day Low | $152.04 | EPS | $-0.69 | |||
| Volume | 895,197 | |||||
